In GBM patients with high VRK1 expression, YBX1 and SOX2 were also overexpressed, suggesting that GSCs in these patients are highly proliferative and more likely to exhibit treatment resistance and tumor recurrence. This evidence concerns the gene VRK1 and neoplasm.